(Q70030398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

D M Jackson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

M Hashizume

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

131-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

The central effects of a novel dopamine agonist

8 October 2019

cites work

1 reference

12 December 2020

Multiple receptors for dopamine

1 reference

12 December 2020

Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine

1 reference

12 December 2020

The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour

1 reference

12 December 2020

Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats.

1 reference

12 December 2020

Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice

1 reference

12 December 2020

Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis

1 reference

12 December 2020

The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists

1 reference

12 December 2020

Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine

1 reference

12 December 2020

Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats

1 reference

12 December 2020

Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

1 reference

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

12 December 2020

Microelectrophoretic studies with 2-bromo-alpha-ergocriptine on dopaminergic neurons in the feline caudate nucleus.

1 reference

12 December 2020

Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

1 reference

12 December 2020

Bromocriptine and dopamine-receptor stimulation

1 reference

12 December 2020

Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.

1 reference

12 December 2020

On the functional role of pre- and postsynaptic catecholamine receptors in brain

1 reference

12 December 2020

Evidence for an irreversible interaction of bromocryptine with central dopamine receptors

1 reference

12 December 2020

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

12 December 2020

SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions

1 reference

12 December 2020

SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons

1 reference

12 December 2020

Stereospecific Antagonism by d-Butaclamol of Dopamine-Induced Relaxation of the Isolated Rabbit Mesenteric Artery

1 reference

12 December 2020

The interactions of bromocriptine and lergotrile with dopamine and α-adrenergic receptors

1 reference

12 December 2020

Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393

1 reference

12 December 2020

Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.

1 reference

12 December 2020

Metabolite involvement in bromocriptine-induced circling behaviour in rodents

1 reference

12 December 2020

Inhibition of neurotransmitter receptor binding by ergot derivatives

1 reference

12 December 2020

Effects of bromocriptine on receptor binding of methionine-enkephalin

1 reference

12 December 2020

Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide

1 reference

12 December 2020

Evidence for selective and long-lasting stimulation of “regulatory” dopamine-receptors by bromocriptine (CB 154)

1 reference

12 December 2020

A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.

1 reference

12 December 2020

A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration

1 reference

12 December 2020

Effects of bromocriptine on the hypothalamo-pituitary axis

1 reference

12 December 2020

Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies.

1 reference

12 December 2020

Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties

1 reference

12 December 2020

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

12 December 2020

Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01244104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2953861%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference